Applicable population Tirpotide: Applicable to long-term weight management for adults with a body mass index (BMI) greater than or equal to 28 (obesity) or greater than or equal to 24 (overweight) and at least one weight-related comorbidity (such as hypertension, dyslipidemia, hyperglycemia, obstructive sleep apnea, cardiovascular disease, etc.) on the basis of controlling diet and increasing exercise
For instance, due to its effects on the nitric oxide pathway and vascular function, it should be carefully assessed when used alongside anticoagulants, vasodilators, or certain gastrointestinal medications
GLP-1 Receptor Agonism: Similar to medications like Semaglutide (found in Ozempic and Wegovy, as well as our Compounded Semaglutide and Oral Semaglutide options), tirzepatides GLP-1 action enhances insulin secretion in a glucose-dependent manner, slows gastric emptying, and reduces glucagon secretion
Room-temp stable, no reconstitution required